Compositions and methods of cell attachment

US2018024116A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018024116-A1
Application numberUS-201715648213-A
CountryUS
Kind codeA1
Filing dateJul 12, 2017
Priority dateJul 12, 2016
Publication dateJan 25, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions, devices and methods are described for improving adhesion, attachment, and/or differentiation of cells in a microfluidic device or chip. In one embodiment, one or more ECM proteins are covalently coupled to the surface of a microchannel of a microfluidic device. The microfluidic devices can be stored or used immediately for culture and/or support of living cells such as mammalian cells, and/or for simulating a function of a tissue, e.g., a liver tissue, muscle tissue, etc. Extended adhesion and viability with sustained function over time is observed.

First claim

Opening claim text (preview).

We claim: 1 . A method of culturing cells, comprising: a) providing a microfluidic device comprising a microchannel comprising a surface, said microchannel in fluidic communication with a fluid source comprising fluid; b) covalently attaching one or more proteins or peptides to said microchannel surface so as to create a treated surface; c) seeding viable cells on said treated surface so as to create attached cells; c) flowing fluid from said fluid source through said microchannel so as to create flowing conditions; and d) culturing said attached cells under said flow conditions such that said cells remain attached and viable for at least 14 days. 2 . The method of claim 1 , wherein said cells are hepatocytes. 3 . The method of claim 2 , further comprising e) assessing viability by measuring the level of activity of one or more cellular enzymes. 4 . The method of claim 3 , wherein said cellular enzyme is a CYP enzyme. 5 . The method of claim 3 , wherein said cellular enzyme is a transaminase. 6 . The method of claim 1 , further comprising e) assessing viability by measuring the level of expression of one or more cellular proteins. 7 . The method of claim 1 , wherein said one or more proteins comprises collagen. 8 . The method of claim 1 , wherein said one or more proteins comprises a mixture of collagen type I, fibronectin and collagen type IV. 9 . The method of claim 1 , wherein said one or more peptides comprises RGD or a peptide comprising the RGD motif. 10 . The method of claim 9 , wherein RGD is covalently attached to said microchannel surface using N-sulphosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate. 11 . A method of culturing cells, comprising: a) providing a microfluidic device comprising a microchannel comprising a surface, said microchannel in fluidic communication with a fluid source comprising fluid; b) covalently attaching one or more proteins or peptides to said microchannel surface so as to create a treated surface; c) seeding viable hepatocytes on said treated surface so as to create attached cells; c) flowing fluid from said fluid source through said microchannel so as to create flowing conditions; and d) culturing said attached cells under said flow conditions such that said cells remain attached and viable for at least 14 days. 12 . The method of claim 11 , wherein said hepatocytes are dog hepatocytes. 13 . The method of claim 11 , further comprising e) assessing viability by measuring the level of activity of one or more cellular enzymes. 14 . The method of claim 13 , wherein said cellular enzyme is a CYP enzyme. 15 . The method of claim 13 , wherein said cellular enzyme is a transaminase. 16 . The method of claim 11 , further comprising e) assessing viability by measuring the level of expression of one or more cellular proteins. 17 . The method of claim 11 , wherein said one or more proteins comprise collagen. 18 . The method of claim 11 , wherein said one or more proteins comprises a mixture of collagen type I, fibronectin and collagen type IV. 19 . The method of claim 18 , wherein said mixture is covalently attached to said microchannel surface using N-sulphosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate. 20 . The method of claim 11 , wherein said one or more peptides comprises RGD or a peptide comprising the RGD motif. 21 . The method of claim 20 , wherein RGD is covalently attached to said microchannel surface using N-sulphosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate. 21 . The method of claim 20 , wherein said microchannel surface is PDMS and is plasma treated prior to step b).

Assignees

Inventors

Classifications

  • Material Coatings (immunocoatings C12M25/00) · CPC title

  • for testing toxicity · CPC title

  • Cross-linking · CPC title

  • Membranes; Filters (filters or filtration in general B01D24/00-B01D41/00) · CPC title

  • C12N5/067Primary

    Hepatocytes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018024116A1 cover?
Compositions, devices and methods are described for improving adhesion, attachment, and/or differentiation of cells in a microfluidic device or chip. In one embodiment, one or more ECM proteins are covalently coupled to the surface of a microchannel of a microfluidic device. The microfluidic devices can be stored or used immediately for culture and/or support of living cells such as mammalian c…
Who is the assignee on this patent?
Emulate Inc
What technology area does this patent fall under?
Primary CPC classification C12N5/067. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jan 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).